Pfizer And AstraZeneca Set To Invest Big In France

Leading healthcare companies Pfizer and AstraZeneca announced new investments in France worth nearly $1 billion.

Pfizer plans to invest 500 million euros ($538.5 million) in France to enhance its research and development work in the country.

AstraZeneca, on the other hand, announced a $388 million investment for its site at Dunkirk.

These investment pledges coincide with President Emmanuel Macron’s annual ‘Choose France’ business summit, where France aims to attract big overseas businesses and investors.

Readers Bureau, Contributor

Please add a comment in the box below or send an email to Call us at 646-874-7976.


Like our Facebook page

Follow us on Twitter

Get Your T-shirt here